SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-242081
Filing Date
2018-08-08
Accepted
2018-08-08 09:02:30
Documents
52
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d546413d10q.htm 10-Q 586515
2 EX-10.1 d546413dex101.htm EX-10.1 497182
3 EX-31.1 d546413dex311.htm EX-31.1 10321
4 EX-31.2 d546413dex312.htm EX-31.2 10301
5 EX-32.1 d546413dex321.htm EX-32.1 5509
  Complete submission text file 0001193125-18-242081.txt   2922388

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT aqxp-20180630.xml EX-101.INS 358080
7 XBRL TAXONOMY EXTENSION SCHEMA aqxp-20180630.xsd EX-101.SCH 27625
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aqxp-20180630_cal.xml EX-101.CAL 37939
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aqxp-20180630_def.xml EX-101.DEF 70334
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE aqxp-20180630_lab.xml EX-101.LAB 234924
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aqxp-20180630_pre.xml EX-101.PRE 159174
Mailing Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5
Business Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5 604-629-9223
AQUINOX PHARMACEUTICALS, INC (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36327 | Film No.: 18999981
SIC: 2834 Pharmaceutical Preparations